Journal of Transcatheter Valve Therapies (JTVT) is a peer-reviewed, open access journal publishing articles on Transcatheter Valve Therapies. Published continuously online, the journal is fully indexed in J-STAGE. JTVT welcomes submissions from around the world.

About the journal

Journal of Transcatheter Valve Therapies is an official journal of Japan Transcatheter Valve Therapies (Society) .

Read more >

Instructions to Authors

Journal of Transcatheter Valve Therapies supplies comprehensive and clear Instructions to Authors, which offer guidance on article types and format, journal policies, and how to submit manuscripts.

Read more >

The journal welcomes submissions from around the world. Please consult the Instructions to Authors and the Author Checklist.

Latest articlesView more articles >

How to Do ItFebruary 13, 2026

Intracardiac Echocardiography via Trans-Jugular Approach for Transcatheter Tricuspid Valve Repair: In Vitro Study of Device Movement for Leaflet Detection

Shingo Kuwata, et al.

Objective: Severe tricuspid regurgitation (TR) is linked to poor prognosis, and transcatheter edge-to-edge repair (Tricuspid-TEER) has become a promising therapeutic option. However, intraprocedural imaging remains challenging. While transesophageal echocardiography (TEE) is the standard, it may not always provide optimal visualization and can cause esophageal injury.

Read full Article >

Case ReportFebruary 11, 2026

Hemolytic Anemia Caused by Paravalvular Regurgitation after Transcatheter Aortic Valve Implantation That Required Aortic Valve Replacement: A Case Report

Hidetaka Kariya, et al.

Objective: We report a rare case of severe hemolytic anemia caused by residual paravalvular leak (PVL) following transcatheter aortic valve implantation (TAVI), which ultimately required surgical aortic valve replacement (AVR).

Read full Article >

Case ReportFebruary 3, 2026

Transcatheter Valve-in-Valve Pulmonary Valve Implantation Using SAPIEN 3 for a Young-Adult Patient with Severe Heart Failure: A Case Report

Yuriko Shima, et al.

Objective: Transcatheter valve-in-valve pulmonary valve implantation (ViV-TPVI) with SAPIEN 3 (Edwards Lifesciences, Irvine, CA, USA) is effective for treating insufficient prosthetic valves in right ventricular outflow tract diseases. SAPIEN 3 is primarily used to replace failed aortic valves; therefore, there is limited published data on the outcomes of its use for ViV-TPVI. In patients with severe heart failure, every procedure can lead to collapse during TPVI. This case report aims to describe the procedural strategy, perioperative management, and short-term outcomes of ViV-TPVI with SAPIEN 3 in a patient with biventricular heart failure, where careful preparation and prerisk assessment were critical to procedural success.

Read full Article >